There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

Brain lesions — areas of brain tissue that show damage from injury or disease — are the biomarker most widely used to determine multiple sclerosis disease progression. But an innovative new study led ...

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

Multiple sclerosis, a complex neurological condition affecting nearly 3 million people worldwide, has long been characterized by its elusiveness. Even as medical imaging technology has advanced ...

BUFFALO, N.Y. – In recent years, researchers studying multiple sclerosis have concluded that white matter lesion volume in the brain, long considered the best way to monitor MS disease progression, ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

Christina Applegate opened up about the symptoms she’s experienced throughout her battle with Multiple Sclerosis (MS) during a recent podcast interview on Monday, March 25. The sitcom star, 52, was ...

Christina Applegate is revealing more about her health challenges. The "Dead to Me" star, 52, opened up about her battle with multiple sclerosis on Monday's episode of Dax Shepard's "Armchair Expert" ...

The combination of cortical lesions and central vein sign in MRI increases the specificity and sensitivity for diagnosing multiple sclerosis. This study suggests that CLs and CVS, when used together, ...

The 52-year-old actress got candid about her medical struggles through the years and how she 'lied' about her cancer battle. Christina Applegate is done with hiding. The 52-year-old actress has been ...

"[These results] show that white matter lesions across all MS patients tend to injure the white matter depression network, which may create a vulnerability for depression in the MS population as a ...